Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Ascenta and sanofi-aventis sign license agreement in oncology

June 8, 2010

Phase I trial data presented on GSK-923295 in solid tumors

June 8, 2010

Lilly claims new hedgehog signaling inhibitors

June 8, 2010

CT-322 is active in phase II trial in recurrent glioblastoma

June 7, 2010

FDA grants orphan drug status to telatinib for gastric cancer

June 7, 2010

Hedgehog signaling inhibitors claimed by Lilly for cancer therapy

June 7, 2010

Phase III RADIANT-3 trial of everolimus meets primary endpoint

June 4, 2010

FDA grants fast track status to AS-1413 for secondary AML

June 4, 2010

REDUCE and CombAT trial data presented on dutasteride in prostate cancer

June 4, 2010

Sunesis receives scientific advice from EMA on voreloxin program

June 3, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...